Table 3a

Univariate and multivariable analysis of motivations for undergoing genetic testing among HNPCC, FAP, and HBOS syndromes: prevention and medical care subscale

Prevention and medical care subscale	n	PMC score, mean (SD)	P value
Cohort
HNPCC	37	45.54 (5.71)
FAP	26	47.80 (6.20)
HBOS	67	42.53 (8.04)	0.004*
Age
<40 years	52	46.01 (6.47)
>40 years	76	43.59 (7.65)	0.06
Gender
Female	105	44.14 (7.40)
Male	24	46.45 (6.28)	0.15
Disease status
Affected	67	43.35 (7.33)
Unaffected	63	45.60 (7.27)	0.08
Education
>College	84	45.37 (6.43)
<College	45	44.14 (7.64)	0.35
Income
<$75 000	52	44.80 (6.75)
>$75 000	70	44.41 (7.76)	0.77
Partner
No	38	45.02 (6.71)
Yes	91	44.38 (7.48)	0.64
Individuals with children
No	31	46.35 (5.05)
Yes	98	44.01 (7.74)	0.11
Risk perception of cancer
High, very high	89	45.17 (6.70)
Average, low, very low	35	44.76 (6.91)	0.76
Perception of test results
Have an altered gene	84	44.07 (7.67)
Do not have an altered gene	27	46.00 (7.03)	0.25

Multiple linear regression analysis	Regression coefficient	P value
*Comparisons post-hoc (HNPCC, P = 0.10; FAP, P = 0.005; Tukey’s test); †the reference group is HBOS.
Intercept	40.84
HNPCC†	2.89	0.05
FAP†	5.47	0.002
Disease status (unaffected)	2.84	0.03
Gender (female)	−0.66	0.69
Age (>40 years)	−0.79	0.58
Individuals with children	−0.87	0.58